ABT
Abbott Laboratories
3월 13일 4:01 PM ET (한국 3/14 05:01)
$108.03
-0.11 ▼ -0.10%
🌙 3월 13일 7:53 PM ET (한국 3/14 08:53)
$108.18
+0.15 ▲ +0.14%
| Index | S&P 500 | P/E | 29.06 | EPS (ttm) | 3.72 | Insider Own | 0.68% | Shs Outstand | 1.74B | Perf Week | -1.4% |
| Market Cap | 187.72B | Forward P/E | 17.29 | EPS next Y | 10.03% | Insider Trans | 0.2% | Shs Float | 1.73B | Perf Month | -4.89% |
| Enterprise Value | 193.56B | PEG | 1.72 | EPS next Q | 1.15 | Inst Own | 81.23% | Short Float | 1.06% | Perf Quarter | -11.85% |
| Income | 6.50B | P/S | 4.23 | EPS this Y | 10.23% | Inst Trans | 0.44% | Short Ratio | 1.9 | Perf Half Y | -18.56% |
| Sales | 44.33B | P/B | 3.6 | EPS next 5Y | 10.07% | ROA | 7.73% | Short Interest | 18.23M | Perf YTD | -13.78% |
| Book/sh | 30.02 | P/C | 21 | EPS past 3/5Y | -1.7% 8.23% | ROE | 13.03% | 52W High | -22.31% ($139.06) | Perf Year | -16.83% |
| Cash/sh | 5.14 | P/FCF | 25.38 | Sales past 3/5Y | 0.51% 5.08% | ROIC | 10.32% | 52W Low | 2.62% ($105.27) | Perf 3Y | 10.02% |
| Dividend Est. | $2.46 (2.27%) | EV/EBITDA | 16.96 | EPS Y/Y TTM | -51.48% | Gross Margin | 52.72% | Volatility(W/M) | 2.57% 1.88% | Perf 5Y | -7.44% |
| Dividend TTM | 2.4 | EV/Sales | 4.37 | Sales Y/Y TTM | 5.67% | Oper. Margin | 18.71% | ATR (14) | 2.42 | Perf 10Y | 167.6% |
| Dividend Ex-Date | 2026/4/15 | Quick Ratio | 1.18 | EPS Q/Q | -80.51% | Profit Margin | 14.66% | RSI (14) | 36.74 | Recom | 1.71 |
| Dividend Gr. 3/5Y | 7.72% 9.42% | Current Ratio | 1.58 | Sales Q/Q | 4.42% | SMA20 | -4.01% ($112.54) | Beta | 0.76 | Target Price | $133.68 |
| Payout | 64.54% | Debt/Eq | 0.27 | Earnings | 1000000 | SMA50 | -5.97% ($114.89) | Rel Volume | 0.92 | Prev Close | $108.14 |
| Employees | 115000 | LT Debt/Eq | 0.21 | EPS/Sales Surpr. | 0.29% -2.89% | SMA200 | -14.46% ($126.29) | Avg Volume(3M) | 9.62M | Price | $108.03 |
| IPO | 1937/3/1 | Option/Short | Yes/Yes | Trades | 63700 | Volume | 8,828,850 | Change | -0.1% |
뉴스 로딩 중...